What is the difference between ICD‑10 code F64.0 (transsexualism) and ICD‑10 code F64.9 (unspecified disorder of sexual preference)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code Clarification: F64.0 vs F64.9

You are asking about F64.0 (transsexualism) versus F64.9, but there appears to be an error in your question—F64.9 is "Gender identity disorder, unspecified," NOT "unspecified disorder of sexual preference." Disorders of sexual preference are coded under F65 in ICD-10, not F64.9.

F64.0: Transsexualism

F64.0 is a specific diagnosis with strict criteria that requires:

  • A persistent desire (minimum 2 years) to live and be accepted as a member of the opposite sex 1
  • Usually accompanied by the wish to make one's body as congruent as possible with the preferred sex through surgery and hormone treatments 1
  • The transsexual identity must be present persistently for at least 2 years 1
  • The disorder cannot be a symptom of another mental disorder or a genetic, intersex, or chromosomal abnormality 1

This is the most specific code within the F64 category and is used when the full diagnostic criteria for transsexualism are met.

F64.9: Gender Identity Disorder, Unspecified

F64.9 is used when:

  • There is a gender identity disorder present but the specific type cannot be determined
  • The clinical presentation doesn't meet full criteria for F64.0 (transsexualism) or other specific F64 subcategories
  • Documentation is insufficient to assign a more specific F64 code

Clinical Coding Decision Algorithm

Use F64.0 when:

  1. The patient explicitly desires to live as the opposite sex
  2. The identity has been persistent for ≥2 years
  3. There is desire for medical/surgical transition
  4. Other mental disorders and intersex conditions are ruled out

Use F64.9 when:

  1. Gender identity concerns exist but don't meet the 2-year threshold
  2. The clinical picture is unclear or evolving
  3. Documentation is incomplete
  4. The patient has gender identity issues that don't fit transsexualism criteria

Important Context

The ICD-10 nomenclature of "gender identity disorder" has fallen out of favor 2. The ICD-11 (which some countries are transitioning to) has moved away from pathologizing language and now uses "Gender Incongruence" in a new chapter on sexual health rather than mental disorders 3, 4. This reflects current understanding that gender diversity is not inherently a mental illness, though the ICD-10 codes remain in use in the United States and other countries for billing purposes 2, 5.

Common Pitfall to Avoid

Do not confuse F64.9 with F65.9 (Disorder of sexual preference, unspecified). F64 codes relate to gender identity, while F65 codes relate to paraphilic disorders/sexual preferences—these are entirely different diagnostic categories 3.

Related Questions

What are the ICD‑11 criteria (code HA60) for diagnosing Gender Incongruence in adolescents and adults?
What is the ICD‑10 classification for female sexual dysfunction?
Which specialist should a transgender patient be referred to for gender‑affirming hormone therapy?
What is the recommended evaluation and management for a cyst that appears separate from the pancreas?
For a female patient with an 11‑year history of schizoaffective disorder, bipolar type, recent discharge on risperidone 3 mg twice daily, buspirone 10 mg three times daily, propranolol 10 mg twice daily, and lithium 300 mg three times daily (added today), metabolic syndrome, prior poor adherence, and no prior long‑acting injectable antipsychotic, what is the optimal medication management plan—including antipsychotic selection (e.g., transition to a long‑acting injectable), mood‑stabilizer dosing and monitoring, anxiety and sleep strategies, and metabolic monitoring?
How do neuromuscular blocking agents affect motor and somatosensory evoked potentials, and what are the recommended strategies for their use during intra‑operative neurophysiological monitoring?
Is heparin prophylaxis indicated for a hospitalized pediatric patient?
I took lorazepam 0.5 mg, clonidine 0.4 mg about two hours ago, and propranolol 0.5 mg half an hour ago; should I be concerned about possible hypotension or other adverse effects?
In an elderly patient, what does leukocytosis combined with rising serum creatinine and decreasing glomerular filtration rate indicate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.